STING1 and neoplasm: Moreover, our results showed that intratumoral (i.t.)treatment of 2′3′-cGAMP (STING agonist) increased the expression of YTHDF1 in tumor-infiltrating DCs in WT mice but not in Sting-KO mice (Figure 3G).